NIH Grantees Win 2015 Nobel Prize in Chemistry
News Oct 08, 2015
Their work focused on mapping, at a molecular level, how cells repair damaged DNA and safeguard the genetic information. They share the award with Tomas Lindahl, Ph.D., of the Francis Crick Institute and Clare Hall Laboratory, Hertfordshire, United Kingdom.
The Royal Swedish Academy of Sciences said their work on DNA repair "has provided fundamental knowledge of how a living cell functions."
Thousands of spontaneous changes to a cell's genome occur on a daily basis while radiation, free radicals and carcinogenic substances can also damage DNA. To keep the information in the genetic instruction book from degrading, a range of molecular systems monitor and repair DNA, in processes that the three award-winning scientists all helped map out.
"This basic understanding about cell function has led to the discovery of the causes of genetic conditions associated with cancer, and is being used to develop new cancer treatments,” said NIH Director Francis S. Collins, M.D., Ph.D. "NIH is proud to have supported this work."
NIH’s National Institute of General Medical Sciences has supported the work of Dr. Sancar since 1982 and continuously supported the work of Dr. Modrich since 1972. Dr. Sancar’s work has also been supported by the National Institute of Environmental Health Sciences, while the National Cancer Institute has also supported the work of Dr. Modrich.
Discovery Advances Efforts to Prevent Spread of CancerNews
Newly identified gene targets could be key to preventing the spread of cancer, new University of Alberta research has shown.
Streaming Protocol Makes Gene Data Sharing Future-ProofNews
The Large Scale Genomics Work Stream of the Global Alliance for Genomics and Health (GA4GH) has announced eight new implementations of its htsget protocol, a standard released in October 2017 for accessing large-scale genomic sequencing data online that does not depend on file transfers. The protocol and interoperability testing are reported in a paper released online this week in the journal Bioinformatics.
Antiviral Gene Vanquishes ZikaNews
It’s been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying. Now, researchers at Albert Einstein College of Medicine, part of Montefiore, have discovered the secret to the gene’s success: The enzyme it codes for generates a compound that stops viruses from replicating. The newly discovered compound, described in today’s online edition of Nature, offers a novel approach for attacking many disease-causing viruses.